Article
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
2022-01-20
Abstract excerpt
The spike glycoprotein of SARS-CoV-2 engages with human angiotensin-converting enzyme 2 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that disrupts this interaction by competitively binding to the spike protein receptor-binding domain. We further generated an engineered bivalent nanobody construct engineered by a flexible linker, and a dimeric Fc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a7c2ccbb-cc21-500d-9f62-9bb33a407285
- DOI
- 10.1101/2022.01.18.476801
